Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Biopharma looks to social media to assist patient recruitment in trials

Canadian company Qu Biologics hopes Twitter and Facebook will help its Crohn's study

 Qu Biologics Twitter trial

The jury may still be out as to the effectiveness of using social media to bolster clinical trials but one Canadian biopharma is undeterred.

Vancouver-based company Qu Biologics last month enrolled the first patient in a phase I/II trial of its novel site specific immunomodulator treatment for Crohn's disease QBECO SSI.

A key part of the company's efforts to boost patient recruitment into its trial is to harness social media to spread its message.

To that end Qu Biologics has a dedicated Twitter account for the trial, @QuCrohnsTrial, along with a similarly focused Facebook page, both of which share information about the trial as well as general information on Crohn's disease.

The Twitter account has been particularly active since its launch in August 2012, notching up more than 1,000 tweets, in the process avoiding the common social media pitfall that often sees new accounts start well but quickly fall into disuse.

For those keen to see how social media, and Twitter in particular, could benefit clinical trials the company's efforts will be of particular interest.

It comes in the wake of Pfizer's vow to continue to experiment with social media to assist trial recruitment, despite the failure last year of its virtual trial, and Novartis' repositioning of some of its efforts in the area from social to mobile.

Although an Australian study last year suggested Facebook adverts could have patient recruitment benefits, there seems to be more concerted industry interest in tapping into online patient communities.

At the forefront of this is PatientsLikeMe, which partnered with Sanofi in May and then last month with inVentiv Health to assist their clinical trials.

4th July 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics